Search

everythinglearnresearchcommunity

for

Search:↓

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

The market for these drugs is expected to grow.

JAK inhibitors are effective treatments for alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Dutasteride safely treats hair loss without harming sexual function.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.